Isabel Iriepa
Toledo, CM 45071, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Structure-based virtual screening, in vitro and in silico analysis identified novel potent m6A demethylase FTO inhibitors as promising neurotherapeutic agents.
Journal: European journal of medicinal chemistry
Published: March 30, 2026
Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-Based Therapy of Parkinson's Disease.
Journal: International journal of molecular sciences
Published: January 30, 2026
Masupirdine, a Selective Serotonin 5‑HT6 Receptor Antagonist for Alzheimer's Disease.
Journal: ACS pharmacology & translational science
Published: December 23, 2025
Zervimesine, a Small Sigma‑2 Receptor Selective Modulator for Alzheimer's Disease.
Journal: ACS medicinal chemistry letters
Published: October 28, 2025
Multicomponent Synthesis of Multi-Target Quinazolines Modulating Cholinesterase, Oxidative Stress, and Amyloid Aggregation Activities for the Therapy of Alzheimer's Disease.
Journal: Molecules (Basel, Switzerland)
Published: September 01, 2025
N-Methyl-N-((1-methyl-5-(3-(piperidin-1-yl)propoxy)-1H-benzo[d]imidazol-2-yl)methyl)prop-2-yn-1-amine (MBA-159), a new multitarget small molecule for the therapy of Alzheimer's disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 28, 2025
2-{N-[ω-(1-Benzylpiperidin-4-yl)alkyl]amino}-6-[(prop-2-yn-1-yl)amino]pyridine-3,5-dicarbonitriles Showing High Affinity for σ1/2 Receptors.
Journal: International journal of molecular sciences
Published: December 19, 2024
Generation and validation of a novel multitarget small molecule in glioblastoma.
Journal: Cell death & disease
Published: November 25, 2024
Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases.
Journal: Journal of medicinal chemistry
Published: September 10, 2024
Discovery of New Highly Potent Histamine H3 Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors.
Journal: ACS chemical neuroscience
Published: August 29, 2024
Last Updated: 09/26/2026